Effects of PTH [1-34] on synoviopathy in an experimental model of osteoarthritis preceded by osteoporosis

Osteoarthritis and Cartilage

Volumn 20, Issue 12, 2012, Pages 1619-1630

  Lugo, L ^a   Villalvilla, A ^a   Gomez R ^a   Bellido, M ^a   Sanchez Pernaute O ^a   Largo, R ^a   Herrero Beaumont, G ^a   Roman Blas, J A ^a  

^a UAM)   (Spain)

Author keywords

Cartilage damage; Osteoarthritis; Osteoporosis; Synovitis

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; COLLAGENASE 3; CYCLINE; CYCLOOXYGENASE 2; GELATINASE B; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE[1-34]; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; KNEE SURGERY; MACROPHAGE; NONHUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNOVIAL FLUID; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; CARTILAGE; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; OSTEOARTHRITIS, KNEE; OSTEOPOROSIS; PARATHYROID HORMONE; RABBITS; RNA; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 84867893460     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.08.010     Document Type: Article

References (43)

1. Herrero-Beaumont G., Roman-Blas J.A., Castañeda S., Jimenez S.A. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin Arthritis Rheum 2009, 39:71-80.
2. Brand K.D., Radin E.L., Dieppe P.A., van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann Rheum Dis 2006, 65:1261-1264.
3. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6:625-635.
4. Oehler S., Neureiter D., Meyer-Scholten C., Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002, 20:633-640.
5. Smith M.D., Triantafillou S., Parker A., Youssef P.P., Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997, 24:365-371.
6. Dijkgraaf L.C., Liem R.S., de Bont L.G. Ultrastructural characteristics of the synovial membrane in osteoarthritic temporomandibular joints. J Oral Maxillofac Surg 1997, 55:1269-1279.
7. Revell P.A., Mayston V., Lalor P., Mapp P. The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies. Ann Rheum Dis 1988, 47:300-307.
8. Ayral X., Pickering E.H., Woodworth T.G., Mackillop N., Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005, 13:361-367.
9. Loeuille D., Chary-Valckenaere I., Champigneulle J., Rat A.C., Toussaint F., Pinzano-Watrin A., et al. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum 2005, 52:3492-3501.
10. Nakamura H., Yoshino S., Kato T., Tsuruha J., Nishioka K. T-cell mediated inflammatory pathway in osteoarthritis. Osteoarthritis Cartilage 1999, 7:401-402.
11. Benito M.J., Veale D.J., FitzGerald O., van den Berg W.B., Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005, 64:1263-1267.
12. Bondeson J., Wainwright S.D., Lauder S., Amos N., Hughes C.E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006, 8:R187.
13. Baker K., Grainger A., Niu J., Clancy M., Guermazi A., Crema M., et al. Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis 2010, 69:1779-1783.
14. Lo G.H., McAlindon T.E., Niu J., Zhang Y., Beals C., Dabrowski C., et al. Bone marrow lesions and joint effusion are strongly and independently associated with weight-bearing pain in knee osteoarthritis: data from the osteoarthritis initiative. Osteoarthritis Cartilage 2009, 17:1562-1569. OAI Investigators Group.
15. Chang J.K., Chang L.H., Hung S.H., Wu S.C., Lee H.Y., Lin Y.S., et al. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats. Arthritis Rheum 2009, 60:3049-3060.
16. Funk J.L., Cordaro L.A., Wei H., Benjamin J.B., Yocum D.E. Synovium as a source of increased amino-terminal parathyroid hormone/related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis. J Clin Invest 1998, 101:1362-1371.
17. Smith M.M., Cake M.A., Ghosh P., Schiavinato A., Read R.A., Little C.B. Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy. Rheumatology (Oxford) 2008, 47:1172-1178.
18. Van Lent P.L., Blom A.B., van der Kraan P., Holthuysen A.E., Vitters E., van Rooijen N., et al. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum 2004, 50:103-111.
19. Morko J., Kiviranta R., Joronen K., Säämänen A.M., Vuorio E., Salminen-Mankonen H. Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K. Arthritis Rheum 2005, 52:3713-3717.
20. Bellido M, Lugo L, Roman-Blas JA, Castañeda S, Calvo E, Largo R, et al. Improving subchondral bone quality ameliorates cartilage degradation in experimental osteoarthritis preceded by osteoporosis. Submitted to Osteoarthritis & Cartilage 2011.
21. Bellido M., Lugo L., Roman-Blas J.A., Castañeda S., Caeiro J.R., Dapia S., et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther 2010, 12:R152.
22. Calvo E., Palacios I., Delgado E., Sanchez-Pernaute O., Largo R., Egido J., et al. Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthritis Cartilage 2004, 12:878-886.
23. Mankin H.J., Dorfman H., Lippiello L., Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971, 53A:523-537.
24. Krenn V., Morawietz L., Häupl T., Neidel J., Petersen I., König A. Grading of chronic synovitis - a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract 2002, 198:317-325.
25. Myers S.L., Brandt K.D., Ehlich J.W., Braunstein E.M., Shelbourne K.D., Heck D.A., et al. Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol 1990, 17:1662-1669.
26. Bondeson J., Blom A.B., Wainwright S., Hughes C., Caterson B., van den Berg W.B. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum 2010, 62:647-657.
27. Goldenberg D.L., Egan M.S., Cohen A.S. Inflammatory synovitis in degenerative joint disease. J Rheumatol 1982, 9:204-209.
28. Haraoui B., Pelletier J.P., Cloutier J.M., Faure M.P., Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum 1991, 34:153-163.
29. Largo R., Díez-Ortego I., Sanchez-Pernaute O., López-Armada M.J., Alvarez-Soria M.A., Egido J., et al. EP2/EP4 signalling inhibits monocyte chemoattractant protein-1 production induced by interleukin 1beta in synovial fibroblasts. Ann Rheum Dis 2004, 63:1197-1204.
30. Blom A.B., van Lent P.L., Libregts S., Holthuysen A.E., van der Kraan P.M., van Rooijen N., et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007, 56:147-157.
31. Firestein G.S., Paine M.M., Littman B.H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 1991, 34:1094-1095.
32. Katschke K.J., Rottman J.B., Ruth J.H., Qin S., Wu L., LaRosa G., et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001, 44:1022-1032.
33. Kanbe K., Takemura T., Takeuchi K., Chen Q., Takagishi K., Inoue K. Synovectomy reduces stromal-cell-derived factor-1 (SDF-1) which is involved in the destruction of cartilage in osteoarthritis and rheumatoid arthritis. J Bone Joint Surg Br 2004, 86:296-300.
34. Zafarullah M., Pelletier J.P., Cloutier J.M., Martel-Pelletier J. Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia. J Rheumatol 1993, 20:693-697.
35. Harigai M., Hara M., Yoshimura T., Leonard E.J., Inoue K., Kashiwazaki S. Monocyte chemoattractant protein-1 (MCP-1) in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993, 69:83-91.
36. Funk J.L., Wei H., Downey K.J., Yocum D., Benjamin J.B., Carley W. Expression of PTHrP and its cognate receptor in the rheumatoid synovial microcirculation. Biochem Biophys Res Commun 2002, 297:890-897.
37. Steenvoorden M.M., Tolboom T.C., van der Pluijm G., Löwik C., Visser C.P., DeGroot J., et al. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther 2006, 8:R165-R174.
38. Cheng S.L., Shao J.S., Halstead L.R., Distelhorst K., Sierra O., Towler D.A. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/beta-catenin signaling and aortic fibrosis in diabetic arteriosclerosis. Circ Res 2010, 107:271-282.
39. Saito M., Marumo K., Kida Y., Ushiku C., Kato S., Takao-Kawabata R., et al. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys. Osteoporos Int 2011, 22:2373-2383.
40. Nissenson R.A. Parathyroid hormone and parathyroid hormone-related protein. Osteoporosis 2008, 284-316. Elsevier, Burlington (MA). R. Marcus, D. Feldman, D.A. Nelson, C.J. Rosen (Eds.).
41. Li X., Liu H., Qin L., Tamasi J., Bergenstock M., Shapses S., et al. Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis. J Biol Chem 2007, 282(45):33086-33097.
42. Aigner T., van der Kraan P., van der Berg W. Osteoarthritis and inflammation - inflammatory changes in osteoarthritic synoviopathy. Osteoarthritis, Inflammation and Degradation 2007, 219-235. IOS Press, Amsterdam. J.A. Buckwalter, M. Lotz, J.F. Stoltz (Eds.).
43. Sampson E.R., Hilton M.J., Tian Y., Chen D., Schwarz E.M., Mooney R.A., et al. Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med 2011, 3:101ra93.